E Valovirta
Overview
Explore the profile of E Valovirta including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
80
Citations
3860
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Bousquet J, Melen E, Haahtela T, Koppelman G, Togias A, Valenta R, et al.
Allergy
. 2023 Feb;
78(5):1169-1203.
PMID: 36799120
Asthma, rhinitis, and atopic dermatitis (AD) are interrelated clinical phenotypes that partly overlap in the human interactome. The concept of "one-airway-one-disease," coined over 20 years ago, is a simplistic approach...
2.
Bedard A, Basagana X, Anto J, Garcia-Aymerich J, Devillier P, Arnavielhe S, et al.
Clin Transl Allergy
. 2020 Dec;
10(1):62.
PMID: 33298191
Background: The analysis of mobile health (mHealth) data has generated innovative insights into improving allergic rhinitis control, but additive information is needed. A cross-sectional real-world observational study was undertaken in...
3.
Pitsios C, Tsoumani M, Bilo M, Sturm G, Rodriguez Del Rio P, Gawlik R, et al.
Clin Transl Allergy
. 2019 Sep;
9:45.
PMID: 31528333
Background: Recommendations on contraindications to allergen immunotherapy (AIT) have been independently developed by National and International Societies/Academies. AIT contraindications are mainly based on case reports, case-series, or experts' opinion, while...
4.
Bousquet J, Bedbrook A, Czarlewski W, Onorato G, Arnavielhe S, Laune D, et al.
Clin Transl Allergy
. 2019 Mar;
9:16.
PMID: 30911372
Aims: Mobile Airways Sentinel NetworK (MASK) belongs to the Fondation Partenariale MACVIA-LR of Montpellier, France and aims to provide an active and healthy life to rhinitis sufferers and to those...
5.
Biedermann T, Winther L, Till S, Panzner P, Knulst A, Valovirta E
Allergy
. 2019 Mar;
74(7):1237-1248.
PMID: 30829410
Birch and other related trees of the families Betulaceae and Fagaceae (alder, hazel, oak, hornbeam, chestnut, and beech) constitute the birch homologous group. This grouping is primarily based on the...
6.
Bousquet J, Arnavielhe S, Bedbrook A, Bewick M, Laune D, Mathieu-Dupas E, et al.
Clin Transl Allergy
. 2018 Nov;
8:45.
PMID: 30386555
mHealth, such as apps running on consumer smart devices is becoming increasingly popular and has the potential to profoundly affect healthcare and health outcomes. However, it may be disruptive and...
7.
Samreth D, Arnavielhe S, Ingenrieth F, Bedbrook A, Onorato G, Murray R, et al.
World Allergy Organ J
. 2018 Aug;
11(1):15.
PMID: 30061979
Background: Collecting data on the localization of users is a key issue for the MASK (Mobile Airways Sentinel networK: the Allergy Diary) App. Data anonymization is a method of sanitization...
8.
Daily allergic multimorbidity in rhinitis using mobile technology: A novel concept of the MASK study
Bousquet J, Devillier P, Anto J, Bewick M, Haahtela T, Arnavielhe S, et al.
Allergy
. 2018 Mar;
73(8):1622-1631.
PMID: 29569295
Background: Multimorbidity in allergic airway diseases is well known, but no data exist about the daily dynamics of symptoms and their impact on work. To better understand this, we aimed...
9.
Bousquet J, Devillier P, Arnavielhe S, Bedbrook A, Alexis-Alexandre G, van Eerd M, et al.
Allergy
. 2018 Jan;
73(9):1763-1774.
PMID: 29336067
Background: Large observational implementation studies are needed to triangulate the findings from randomized control trials as they reflect "real-world" everyday practice. In a pilot study, we attempted to provide additional...
10.
Pfaar O, Bonini S, Cardona V, Demoly P, Jakob T, Jutel M, et al.
Allergy
. 2017 Nov;
73 Suppl 104:5-23.
PMID: 29171712
The Future of the Allergists and Specific Immunotherapy (FASIT) workshop provides a regular platform for global experts from academia, allergy clinics, regulatory authorities and industry to review developments in the...